As Seen From Here cover art

All Episodes

As Seen From Here — 460 episodes

#
Title
1

ASFH Intravitreal Steroid Implants

2

ASFH Autologous Retinal Transplantation Pt. 2

3

ASFH Autologous Retina Transplantation

4

ASFH IOP Control and RNFL Loss

5

ASFH A Brief Update

6

ASFH Predicting DMEK Outcomes

7

ASFH An Implant to Restore Color Vision

8

ASFH Treating Geographic Atrophy

9

ASFH Covid and Surgical Devices

10

ASFH OCTA, Glaucoma, and Focal Loss

11

ASFH Combining Topical and Intracameral Antibiotics

12

ASFH Comparing Meibomian Gland Thermal Treatment Devices

13

ASFH Gene Therapy in Clinical Practice

14

ASFH Combining Intracameral Antibiotics, Steroids, and NSAIDs for Cataract Surgery

15

ASFH Implanting an Artificial Retina – part 2

16

ASFH Quick Look with Nicole Fram

17

ASFH Quick Look with Sam Garg

18

ASFH Quick Look with Elizabeth Yeu

19

ASFH Quick Look with Daniel Chang

20

ASFH Quick Look with Eric Donnenfeld

21

ASFH Implanting an Artificial Retina – part 1

22

ASFH Quick Look with Vance Thompson

23

ASFH Quick Look with Kevin Miller

24

ASFH The Keratoconus Cataract Trifecta

25

This week's episode will be delayed by 1 week

26

ASFH Preventing Myopia

27

ASFH When Dry Eye is Not Dry Eye at AAO 2019

28

ASFH The Efficacy of Repeat SLT

29

ASFH Removing Descemet’s Membrane, Removing Trabecular Meshwork at AAO 2019

30

ASFH Deep Learning for Geographic Atrophy

31

ASFH Toric IOL Rotation and Re-Rotation at AAO 2019

32

ASFH Advanced Cataract Surgery Technologies -- sponsored by Alcon

33

ASFH It’s All About the Iris at AAO 2019

34

ASFH OCTA Thresholding

35

ASFH Castroviejo Lecture on Acanthamoebal Keratitis at AAO 2019

36

ASFH Adipose-Derived Stem Cells for Keratoconus

37

ASFH Children with Keratoconus and Fungal Keratitis at AAO 2019

38

ASFH IOL Calculation in Keratoconus

39

ASFH Laser Scleral Microperforation and Vitrectomy for the Cataract Surgeon at ASCRS 2019

40

ASFH OCT and Alzheimer’s Disease

41

ASFH MIGS in 2019 and Depot Glaucoma Medications at ASCRS

42

ASFH Natural Language Processing and Ophthalmology

43

Post-Operative IOL Modification and Optical Aberrations after DMEK at ASCRS 2019

44

ASFH Endothelial Cell Density and DSAEK

45

ASFH Intraoperative Anterior Segment OCT and Clinical Optics in Cataract Surgery at ASCRS 2019

46

ASFH SIA for Geeks

47

ASFH SIA: A New Paradigm

48

ASFH MIGS, Hyphema, and Hysteresis at Surgical Summit 2019

49

ASFH Trabecular Meshwork Bypass Devices and Tube Shunts at Surgical Summit 2019

50

ASFH The LAMP Study for Control of Progressive Myopia

51

ASFH UGH Syndrome with Glued Haptics and an American study of intracameral antibiotics at Surgical Summit 2019

52

ASFH Presbyopia

53

ASFH Pseudoexfoliation and Regulatory Update at Surgical Summit 2019

54

ASFH Stroke and Acute Retinal Ischemia -- part 2

55

ASFH Stroke and Acute Retinal Ischemia -- part 1

56

ASFH Unusual Lasers at AAO 2018

57

ASFH The Context of Glaucoma

58

ASFH New Imaging at AAO 2018

59

ASFH Endocyclophotocoagulation in Uncontrolled Glaucoma

60

ASFH Mobilizing the Endothelium and Targeted Crosslinking and at AAO 2018

61

ASFH Kahook Goniotomy as a Stand-Alone Procedure -- part 2

62

ASFH Kahook Goniotomy as a Stand-Alone Procedure - part 1

63

ASFH Retina for the Non-Retinologist at COS 2018

64

ASFH Intracameral Depot Steroid

65

ASFH Adding MIGS to Your Practice and Binkhorst Lecture at ASCRS 2018

66

ASFH Big Data in Ophthalmology

67

ASFH Fixing IOL Problems at ASCRS 2018

68

ASFH Eye Dropping

69

ASFH Perioperative Cataract Refractive and OSD Management

70

ASFH Infectious Uveitis

71

ASFH Corneal Neuropathic Pain at ASCRS

72

ASFH The Role of Intraocular Pressure Variation in the Development of Open-Angle Glaucoma

73

ASFH Targeted Crosslinking and Sterilization Guidelines at ASCRS

74

ASFH Refractive Surgery Eyedrops and CMV Uveitis at APAO

75

ASFH Teleophthalmology

76

ASFH Glaucoma as Neurodegeneration and Post-LASIK Ectasia at APAO

77

ASFH Ganglion Cell Analysis in Advanced Glaucoma

78

ASFH Visual Manifestations of Migraines and Fungal Keratitis at AAO 2017

79

ASFH The Future of AMD

80

ASFH Genetic Testing for Retinoblastoma and Room for MIGS at AAO 2017

81

ASFH Xen vs Trabeculectomy -- part 2

82

ASFH Xen vs Trabeculectomy

83

ASFH Anti-Integrin Therapy and Brillouin Microscopy at the AAO

84

ASFH YAG Vitreolysis for Floaters

85

ASFH Crosslinking and AI Lens Calculations at ESCRS 2017

86

ASFH Retinal Detachment After YAG Capsulotomy

87

ASFH IOL Materials and a Component IOL at APACRS

88

ASFH Optic Nerve Drusen

89

ASFH Femto for Challenging Cataracts and Opportunities in for Cataract Surgery in China

90

Repeat Upload (corrected) ASFH Beauty is in the Eye of the Cosmetic Wearer -- part 2

91

ASFH Beauty is in the Eye of the Cosmetic Wearer -- part 2

92

ASFH Beauty is in the Eye of the Cosmetic Wearer -- part 1

93

ASFH Boris Malyugin and Adi Abulafia at ASCRS 2017

94

ASFH IOL Scaffold and IOL Gluing for Capsular Rupture

95

The Future of MIGS at ASCRS 2017

96

ASFH ROCK the Endothelium

97

ASFH IOL Selection for Patients with Irregular Corneas at ASCRS

98

ASFH CMV Endotheliitis

99

ASFH New Glaucoma Medications and Stabilizing the Capsular Bag at the 2017 Surgical Summit

100

ASFH Tissue Glues for Pterygium Surgery

101

ASFH CMV Endotheliitis and Pterygium Outcomes at The 2016 Asia Cornea Society

102

ASFH The Alpha and Omega of Fish Oil and Ocular Surface Disease -- part 2

103

ASFH The Alpha and Omega of Fish Oil and Ocular Surface Disease -- part 1

104

ASFH Molecular Markers for Keratoconus and Thygeson’s in Children

105

ASFH The Glaucoma Contact Lens -- part 2

106

ASFH The Glaucoma Contact Lens -- part 1

107

ASFH Electrostimulated Accommodation and Fibrinoid Reaction During DMEK at AAO

108

ASFH OCTA, DME, and Anti-VEGF Therapy

109

Targeted Tumor Therapy and Cataract Surgery in Developing Nations at AAO

110

ASFH Giant Cell Arteritis

111

ASFH Intraoperative OCT and Microsporidial Keratitis at APACRS

112

ASFH Intracameral Antibiotics: Why Not?

113

ASFH Supplementary IOLs, Putting Them in and Taking Them Out at APACRS 2016

114

ASFH 2016 Revision of Plaquenil Screening Guidelines -- part 2

115

ASFH 2016 Revision of Plaquenil Screening Guidelines -- part 1

116

ASFH Endocyclophotocoagulation at ASCRS

117

ASFH Progressive Myopia and National Intervention

118

ASFH New IOL Ideas at the 2016 ASCRS Annual Meeting

119

ASFH Vitreous Adhesion and the READ-3 Study

120

ASFH Maximizing MIGS at ASCRS 2016

121

ASFH Aflibercept for Retinal Vein Occlusion

122

ASFH Anthony Aldave and Vishal Jhanji at the 2016 World Ophthalmology Congress

123

ASFH iStent Results in Clinical Practice

124

ASFH Shamira Perera, MD and Sheraz M. Daya, MD at the World Ophthalmology Congress

125

ASFH Automating Capsulotomy Without Femto

126

ASFH Richard Packard and Bruce Koffler at the WOC

127

ASFH Fungal Keratitis in Endothelial Keratoplasty

128

ASFH Crosslinked Corneal Biomechanics and a New MIGS Device

129

ASFH Glaucoma and OCT Angiography

130

ASFH Alternatives to Tonometry and Glaucoma as Aging

131

ASFH AMD and Calcium Supplementation

132

ASFH IOLs in the Vitreous and in the Future

133

ASFH Gene Expression and Sarcoid

134

ASFH Peng Khaw at the 2015 APACRS

135

ASFH Clear Lens Extraction for Chronic Angle Closure

136

ASFH Slowing Myopic Progression in Children

137

ASFH Lowering the Argentinian Flag

138

ASFH Toric IOL Positioning in Small Pupils and Strategies for Soft Cataracts

139

ASFH IOL Calculation After RK

140

ASFH Femto AK Fidelity and Crosslinking Consistency at ESCRS

141

ASFH Cor-T Predicts

142

ASFH Managing Keratoconus without Keratoplasty at ESCRS

143

ASFH Tear Film Homeostasis

144

ASFH Robert Weinstock and Robert Cionni at SideXSide

145

ASFH Treating Demodex With Ivermectin

146

ASFH Sonia Yoo and Abhay and Shail Vasavada at ESCRS

147

ASFH Hydrogel Tissue Glue

148

ASFH Doug Rhee and Bonnie Henderson at SideXSide

149

ASFH The Long-Term Stability of LASIK Correction

150

ASFH MIGS for Advanced Glaucoma and Premium IOLs in the Context of Tear Layer Abnormalities

151

ASFH MIGS and MICS IOLs

152

ASFH New IOLs at the APACRS

153

ASFH The Quantum Retina

154

ASFH OCT Angiography and Glaucoma

155

ASFH Nitin Anand and Sri Ganesh

156

ASFH Corneal Hysteresis

157

ASFH Karl Brasse and Günther Grabner

158

ASFH Scleral Lenses – part 2

159

ASFH Scleral Lenses – part 1

160

ASFH Peter Barry on the FLACS Study

161

ASFH Sumitra Khandelwal and Sam Garg at the 2014 COS

162

ASFH Refractive Surgery and Corneal Biomechanics – part 2

163

ASFH Refractive Surgery and Corneal Biomechanics – part 1

164

ASFH Graham Barrett and Noel Alpins

165

ASFH Rituximab and Orbital Inflammatory Disease

166

ASFH Drs Koch and MacDonald at the ASCRS in Boston

167

ASFH SNiPs and Ranibizumab

168

ASFH Nathan Radcliffe and Scott MacRae at the AAO

169

ASFH Allaying the Itch

170

ASFH OCT Angiography

171

ASFH Live From ASCRS Winter Update with David Chang

172

ASFH Live from Winter Update with Brendan Moriarty

173

ASFH Live from Winter Update with Brock Bakewell

174

ASFH Live from Winter Update with Roger Steinert

175

ASFH Orthokeratology

176

ASFH Pedram Hamrah and Kathryn Hatch

177

ASFH Plaquenil Screening and Cost part 2

178

ASFH Plaquenil Screening and Cost -- part 1

179

ASFH Drs Dua and Hafezi

180

ASFH DARPins for DME

181

ASFH Ring to Prevent PCO

182

ASFH Red Flags for Keratoprostheses

183

ASFH Clive Peckar and Oliver Findl

184

ASFH Vernal Keratoconjunctivitis

185

ASFH Boris Malyugan and Bonnie Henderson

186

ASFH Guidelines for Plaquenil Screening

187

ASFH Arthur Benjamin on post-operative ametropia and Dandapani Ramamurthy on toric keratoconus

188

ASFH Contact Lens Related Limbal Stem Cell Deficiency

189

ASFH Zoltan Nagy on easing into femtosecond cataract surgery and John Kanellopoulos on high fluence riboflavin crosslinking

190

ASFH Treating CRVO

191

ASFH Amar Agarwal on fixating IOLs with glue and Nick Mamalis on TASS

192

ASFH Presbyopic IOLs and Stone Soup – part 2

193

ASFH Presbyopic IOLs and Stone Soup – part 1

194

ASFH The Shifting Sands of Keratometry

195

ASFH Rick Lewis on New Glaucoma Technologies

196

ASFH The Case for Intracameral Antibiotics -- part 2

197

ASFH The Case for Intracameral Antibiotics – part 1

198

ASFH Live at the ASCRS Winter Update in beautiful Aventura Florida February 18, 2013

199

ASFH Live at the ASCRS Winter Update in beautiful Aventura Florida February 17, 2013

200

ASFH Live at the ASCRS Winter Update in beautiful Aventura Florida February 16, 2013

201

ASFH Cataract Extraction and Intraocular Pressure Reduction -- part 2

202

ASFH Cataract Extraction and Intraocular Pressure Reduction -- part 1

203

ASFH Herpes Simplex in Kids

204

ASFH AREDS2

205

ASFH Cataract Surgery and AMD

206

ASFH AMD and Cognitive Impairment

207

ASFH PVD After Cataract Extraction

208

ASFH Statins and Glaucoma

209

ASFH Putting the Iris in Its Place

210

ASFH Reunited

211

ASFH Putting a Square Edge in a Round Hole

212

ASFH Glaucoma 2.0 – part 2

213

ASFH Glaucoma 2.0 -- part 1

214

ASFH Experience with the Femtosecond Laser – part 2

215

ASFH Experience with the Femtosecond Laser – part 1

216

ASFH Macular Folds

217

ASFH Blazing PASCAL

218

ASFH Heeding Disruption (corrected)

219

ASFH Heeding Disruption

220

ASFH Getting Rid of the Blues

221

ASFH What Comes Around Had Better Not Go Around!

222

ASFH Separation Anxiety – part 2

223

ASFH Separation Anxiety – part 1

224

ASFH When Being Thin Doesn’t Matter

225

ASFH Low ATOMic Numbers

226

ASFH Aspirin and AMD

227

ASFH Look Deeply into My Eyes

228

ASFH Aberrant Stability

229

ASFH TASS at Aravind

230

ASFH Tackling Uveitic CME – part 2

231

ASFH Tackling Uveitic CME - part 1

232

ASFH Emmetropization: focusing on the periphery – part 2

233

ASFH Emmetropization: focusing on the periphery part 1

234

ASFH Reticular Macular Disease -- part 2

235

ASFH Reticular Macular Disease -- part 1

236

ASFH The Scottish Retinal Detachment Study

237

ASFH Amniotic Membrane Grafts in Stevens Johnson Syndrome – part 2

238

ASFH Amniotic Membrane Grafts in Stevens Johnson Syndrome – part 1

239

ASFH All Cruelty Springs from Weakness

240

ASFH The Field of the Prepared Mind

241

ASFH A Glaucoma by Any Other Name

242

ASFH The Future is Now

243

ASFH: Brimonidine and Neuroprotection

244

ASFH Complex Cataracts at ASCRS Winter Update

245

ASFH The Dawn of the Modern Age

246

ASFH Deconing -- part 2

247

ASFH Deconing part 1

248

ASFH 2011 Winter Update -- Jan 31

249

ASFH 2011 Winter Update -- Jan 30

250

ASFH 2011 Winter Update -- Jan 29

251

ASFH A Drinking Problem

252

ASFH When Anti-VEGF Agents Fail

253

ASFH Angioid Streaks and Ranibizumab

254

ASFH The Very Small part 3

255

ASFH The Very Small part 2

256

ASFH The Very Small part 1

257

ASFH Wherefore Art Thou, Astigmatism?

258

ASFH Ossifying Lenses

259

ASFH IFIS Histology and Manifestations, part 2

260

ASFH IFIS Histology and Manifestations, part 1

261

ASFH Eating from the Tree of Knowledge

262

ASFH Going the Other Way

263

ASFH Floppy Eyelid Syndrome: the solution

264

ASFH Floppy Eyelid Syndrome: the problem

265

ASFH Limbus on the Move!

266

ASFH: Post-Operative Endophthalmitis: a population-based study

267

ASFH: Limbal Stem Cell Grafts

268

ASFH part 2: CNV and Anti-VEGF Therapy

269

ASFH: The Heritability of IOP and C/D

270

part 1: CNV and Anti-VEGF Therapy

271

ASFH A Sign of Omission

272

ASFH Smoking is Bad

273

ASFH Heads Up!

274

ASFH The Pressure Head

275

ASFH No Need to SWAP

276

ASFH The Significance of Disc Hemorrhages

277

ASFH Treating Submacular Hemorrhages

278

ASFH The Elimination of Infectious Trachoma

279

ASFH Not So Soft AirSoft

280

ASFH Pseudopods Abound part 2

281

ASFH Pseudopods Abound!

282

ASFH TVT at 3 part 2

283

ASFH TVT at 3

284

ASFH Keeping an Even Keel on IOP

285

ASFH The Cataract Time Machine

286

ASFH Divorcing Form From Function in Glaucoma

287

ASFH Ranibizumab and Uveitic CME

288

ASFH Diabetic Retinopathy and Phacoemulsification

289

ASFH Quantifying the Disk at Risk

290

ASFH Canaloplasty

291

ASFH The Portable Expert

292

ASFH Secret Thyroid Eye Disease

293

ASFH The Summer of Our Discontent

294

ASFH Biologic Warfare on Uveitis part 2

295

ASFH Biologic Warfare on Uveitis part 1

296

ASFH ATOM Redux

297

ASFH Obscured By Smoke

298

ASFH I’m Ready for My Close-Up

299

ASFH Under the Influence

300

ASFH Presbyopic IOLs part 2

301

ASFH Presbyopic IOLs part 1

302

ASFH Behçet’s in Kids

303

ASFH The Surprising Story of Microbial Keratitis

304

ASFH The Inelastic Capsule

305

ASFH Glaucoma Twins

306

ASFH Fractals and the Retina

307

ASFH Fractals

308

ASFH Migraines and the Retina

309

ASFH Retinal Implantation

310

ASFH AMD and the Sun

311

ASFH Combating Rubeosis

312

ASFH TASS

313

ASFH CSF Pressure and Glaucoma

314

ASFH CAM for Glaucoma

315

ASFH VEGF TRAP

316

ASFH Toric IOLs

317

ASFH Riboflavin-UVA Crosslinking for Keratoectasia part 2

318

ASFH Riboflavin-UVA Crosslinking for Keratoectasia – part 1

319

ASFH Prostaglandin Analogs: Risks, Benefits, Alternatives

320

ASFH The Genetics of Myopia

321

ASFH Is Intracameral Lidocaine Worthwhile?

322

ASFH Complement Factor H and Response to Therapy

323

ASFH CIGTS 9 Years Out

324

ASFH Grid Laser and Triamcinolone for Diabetic Macular Edema

325

ASFH Building a Better Surgeon

326

ASFH Treating Myopic CNV

327

ASFH Post-Cataract CME

328

ASFH A Vaccine for Fuchs Heterochromic Iridocyclitis

329

ASFH I’ll Have My IVTA Neat

330

ASFH Dropping the Lens

331

ASFH Trading Angle Closure for Bullae

332

A Letter to Listeners

333

ASFH The Champagne Cork Cannula

334

ASFH Complement Factor H and AMD – part 2

335

ASFH Complement Factor H and AMD – part 1

336

ASFH The ARIC Study

337

ASFH Delayed Intraocular Foreign Body Removal During Operations Iraqi Freedom and Enduring Freedom

338

ASFH PCO and IOL Design

339

ASFH Dry Eye and Hinge Position of a Femtosecond Laser Flap

340

ASFH Glaucoma, Cataracts, and Perioperative Pressure

341

ASFH Is Thygeson’s Caused By HSV?

342

ASFH What is Therapy for Neovascular AMD Worth?

343

ASFH Glaucoma & Age, Pupil Size & Rhexis

344

ASFH IFIS

345

ASFH Short Legged Beasties

346

ASFH The Persistence of Therapy

347

ASFH NAION After Cataract Extraction

348

ASFH Assessing Therapy for BRVO

349

ASFH Managing Stage 4 ROP

350

ASFH Wavefront-Optimized Surface Ablation vs LASIK

351

ASFH Safety in Numbers

352

ASFH Paying for Prophylaxis

353

ASFH IOL Decentration and Tilt

354

ASFH Square Cataract Wounds

355

ASFH MRSA Keratitis After Refractive Surgery

356

ASFH Uveitis Associated with Juvenile Idiopathic Arthritis

357

ASFH Endophthalmitis and Fourth Generation Fluoroquinolones

358

ASFH Potential Acuity Testing

359

ASFH Refractive and Diffractive Multifocal IOLs

360

ASFH Pseudophakic Retinal Detachment

361

ASFH 2nd Anniversary Special! OHTS, HRT, and the EGPS

362

ASFH Post-Cataract Refractive Surprise

363

ASFH Induced Astigmatism After Phacoemulsification

364

ASFH Treating Acute Retinal Necrosis with PO Medication

365

ASFH Robots!

366

ASFH Fool Me Once...

367

ASFH Sutureless Cataract Extraction and the Himalayan Cataract Project

368

ASFH Exfoliation, Cataract, and IOP

369

ASFH The Reykjavik Eye Study

370

ASFH The Power of the ATOM

371

ASFH Web 2.0 and Medical Information

372

ASFH SLT Versus ALT: a randomized clinical trial

373

ASFH Uveal Melanomas: the broad view

374

ASFH Intravitreal Triamcinolone – How Much Is Enough?

375

ASFH Retinal Vascular Caliber and Diabetic Retinopathy

376

ASFH Periocular Skin Cancer

377

ASFH Ranibizumab (Lucentis) Trials

378

ASFH Floppy Iris Syndrome and Its Associations

379

ASFH A Pill to Prevent Cataracts

380

ASFH part 2 -- The TVT Study: One Year Results

381

ASFH part 1 -- The TVT Study: One Year Results

382

ASFH Taking the Ambiguity Out of Testing for Giant Cell Arteritis

383

ASFH The Dark Side of Prostaglandin Analogs

384

ASFH When to Treat OHT

385

ASFH Medical vs Surgical Therapy for Overnight IOP Control

386

ASFH Not So Idiopathic Uveitis

387

ASFH Sirsasana and IOP

388

ASFH The Spotlight Turned on Us -- Epidemiology of Medical Treatment for Glaucoma and Ocular Hypertension

389

ASFH Open Angle Glaucoma and Diabetes

390

ASFH Smoke Gets in Your Eyes

391

ASFH Small Choroidal Melanocytic Lesions

392

ASFH Cataract Extraction and Diabetic Retinopathy

393

ASFH Do We Need To Patch at All? Anisometropic Amblyopia part 2

394

ASFH Paring Down Patching for Anisometropic Amblyopia

395

ASFH Combining PDT with Triamcinolone

396

ASFH part 3 of 3 IOL Calculation After Excimer Refractive Surgery

397

ASFH part 2 of 3 IOL Calculation After Excimer Refractive Surgery

398

ASFH part 1 of 3 - IOL Calculation After Excimer Refractive Surgery

399

ASFH Ophthalmology and the Developing World

400

ASFH Amiodarone and Optic Neuropathy

401

ASFH Treating Submacular Hemorrhages with TPA

402

ASFH Cyclosporin for Allergic Conjunctivitis

403

ASFH Repeated Intravitreal Triamcinolone

404

ASFH Sclerosing Therapy for Orbital Lymphangiomas

405

ASFH Deep Lamellar Endothelial Keratoplasty (DLEK)

406

ASFH A New Endothelial Corneal Dystrophy

407

ASFH Staining Vitreous with Triamcinolone

408

ASFH IOP Asymmetry and Implications

409

ASFH Anecortave vs Verteporforin

410

ASFH: Anterior Capsular Opacity and Lens Design

411

ASFH: Alcohol Delamination for Recurrent Corneal Erosions

412

ASFH: The Big Bubble Technique

413

ASFH: NAION and Erectile Dysfunction Medications

414

ASFH: CAM in Ophthalmology

415

ASFH: New Concepts in IOLs (part 2)

416

ASFH: New Concepts in IOLs (part 1)

417

ASFH: Glaucoma Risk in Siblings

418

ASFH: NSAIDs and CME

419

ASFH: PRK for Anisometropic Amblyopia

420

ASFH: Opacifying IOLs

421

ASFH: Hydroxychloroquine (Plaquenil) and Multifocal ERG

422

ASFH: Dry Eye and Visual Acuity

423

ASFH: New Year’s Uveitis Blowout!

424

ASFH: Endophthalmitis in South India

425

ASFH: Conductive Keratoplasty after LASIK

426

Subject: Treating Vitreous Hemorrhage with Highly Purified Hyaluronidase

427

ASFH: Amniotic Membrane Transplantation After Burns

428

ASFH: Is that IOL Cracked?

429

ASFH: Predicting Conversion from OHT to Glaucoma

430

ASFH: Keratoconus and Risk

431

ASFH: Water Drinking Test in Glaucoma

432

ASFH: Dry Eye: at the Fore

433

ASFH: Bimanual Microincision Phacoemulsification

434

ASFH: IOL Calculation After LASIK

435

ASFH: Wavefront, LASIK, and Symptoms

436

ASFH: Statins and AMD

437

ASFH: The TVT Study

438

ASFH: Understanding Wavefront: a podcast special

439

ASFH: Genetics and AMD

440

Angiogenesis

441

Giant Cell Arteritis: Symptoms and Histopathology

442

Surgical vs Medical Initial Therapy for Glaucoma

443

Refractive Lens Exchange

444

Remixatorium #16

445

06-26-05 As Seen From Here

446

06-19-05 As Seen From Here

447

06-11-05 As Seen From Here

448

06-05-05 As Seen From Here

449

05-29-05 As Seen From Here

450

05-22-05 As Seen From Here

451

05-15-05 As Seen From Here

452

05-08-05 As Seen From Here

453

05012005 As Seen From Here

454

Fibrin Glue for Pterygia, Punctal Plugs and Pyogenic Granulomas

455

The Ontogeny of Phacoemulsification

456

04-10-2005 As Seen From Here

457

04-03-2005 As Seen From Here

458

03-27-05 ASFH

459

03-20-05 As Seen From Here

460

As Seen From Here